ELEVATED LEVELS OF ACTIVITIES OF BETA-HEXOSAMINIDASE AND ALPHA-MANNOSIDASE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS

被引:11
|
作者
LUGERING, N
STOLL, R
SIEKMANN, A
FAULHABER, J
HEESE, C
DIETRICH, O
KUCHARZIK, T
BUSCH, H
HASILIK, A
DOMSCHKE, W
机构
[1] UNIV MUNSTER,DEPT MED D,D-48129 MUNSTER,GERMANY
[2] UNIV MUNSTER,DEPT BIOCHEM & PATHOBIOCHEM,D-48129 MUNSTER,GERMANY
来源
JOURNAL OF INFECTIOUS DISEASES | 1995年 / 171卷 / 03期
关键词
D O I
10.1093/infdis/171.3.683
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine their value as markers of the clinical stage of human immunodeficiency virus (HIV) disease, plasma activities of lysosomal glycosidases were determined in the plasma of 97 HIV-infected patients: molecular forms of cathepsin D were characterized by Western blot to examine the mode of enzyme release. In patients with Centers for Disease Control and Prevention stage II and III of HIV disease, plasma activity of beta-hexosaminidase was significantly increased. In patients with stage III infection, alpha-mannosidase activity was also significantly increased and cathepsin D was elevated and present only in its premature form. Thus, determination of plasma activities of beta-hexosaminidase and alpha-mannosidase in HIV-positive persons may be useful for distinguishing the clinical stage of disease. The elevation of precursors of cathepsin D in patients with stage III HIV disease indicates that secretion of lysosomal enzymes rather than leakage of enzymes from damaged cells is markedly elevated.
引用
收藏
页码:683 / 686
页数:4
相关论文
共 50 条
  • [41] SELENIUM SUPPLEMENTATION OF SYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS
    OLMSTED, L
    SCHRAUZER, GN
    FLORESARCE, M
    DOWD, J
    BIOLOGICAL TRACE ELEMENT RESEARCH, 1989, 20 (1-2) : 59 - 65
  • [42] THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH INTRAVENOUS IMMUNOGLOBULIN
    YAP, PL
    WILLIAMS, PE
    JOURNAL OF HOSPITAL INFECTION, 1988, 12 : 35 - 46
  • [43] Mantle cell lymphoma in human immunodeficiency virus-infected patients
    Bertinchamp, Remi
    Garzaro, Margaux
    Boutboul, David
    Galicier, Lionel
    Meignin, Veronique
    Calvani, Julien
    Djerad, Mohammed El Hadi
    Rozenbaum, Willy
    Simon, Philippe
    Oksenhendler, Eric
    Gerard, Laurence
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 199 (05) : 782 - 784
  • [44] Acute myocardial infarction in human immunodeficiency virus-infected patients
    Matetzky, S
    Domingo, M
    Kar, S
    Noc, M
    Shah, PK
    Kaul, S
    Daar, E
    Cercek, B
    ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (04) : 457 - 460
  • [45] Scanning Laser Polarimetry in Human Immunodeficiency Virus-Infected Patients
    Kozner, Pavel
    Filous, Ales
    Jilich, David
    Brozek, Bretislav
    Maly, Marek
    Machala, Ladislav
    NEURO-OPHTHALMOLOGY, 2011, 35 (04) : 187 - 190
  • [46] Oral candidiasis in human immunodeficiency virus-infected patients.
    Jaramillo, A
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : A230 - A230
  • [47] Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients
    Ribera, E
    Ocana, I
    deOtero, J
    Cortes, E
    Gasser, I
    Pahissa, A
    AMERICAN JOURNAL OF MEDICINE, 1996, 100 (05): : 496 - 501
  • [48] Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients
    LagunadelEstal, P
    MoyaMir, MS
    AMERICAN JOURNAL OF MEDICINE, 1997, 102 (02): : 222 - 222
  • [49] EVALUATION OF THE NECK MASS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS
    LEE, KC
    CHEUNG, SW
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 1992, 25 (06) : 1287 - 1305
  • [50] Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients
    Turner, BJ
    JOURNAL OF INFECTIOUS DISEASES, 2002, 185 : S143 - S151